The anti-apoptotic protein Bcl-2 is upregulated in several cancers, including diffuse large B-cell lymphoma (DLBCL) and chronic lymphocytic leukemia (CLL). The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.